BOSTON (AP) _ Pieris Pharmaceuticals Inc. (PIRS) on Wednesday reported a loss of $9.7 million in its third quarter.
On a per-share basis, the Boston-based company said it had a loss of 13 cents.
The biopharmaceutical company posted revenue of $5.4 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PIRS at https://www.zacks.com/ap/PIRS
/Advanced%20Micro%20Devices%20Inc_%20office%20sign-by%20Poetra_RH%20via%20Shutterstock.jpg)
/Chipset%20held%20over%20rush%20hour%20traffic%20by%20Jae%20Young%20Ju%20via%20iStock.jpg)
/The%20sign%20for%20Marvell%20Technology%20out%20front%20of%20a%20corporate%20office%20by%20Valeriya%20Zankovych%20via%20Shutterstock.jpg)